Barrett's, blood groups and progression to oesophageal cancer: Is nitric oxide the link?

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 9, 2011, Pages 801-806

  Caygill, Christine P J ^a   Royston, Christine ^b   Charlett, André ^c   Wall, Christine M ^a   Gatenby, Piers A C ^a   Ramus, James R ^a   Watson, Anthony ^a   Winslet, Marc ^a   Hourigan, Christopher S ^d   Dev Bardhan, Karna ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Rotherham NHS Foundation Trust   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP O ANTIGEN; RHESUS D ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BARRETT ESOPHAGUS; BLOOD DONOR; BLOOD GROUP; BLOOD GROUP O; BLOOD GROUP RH; BLOOD TRANSFUSION; CANCER GROWTH; CANCER RISK; CHILD; COLUMNAR LINED OESOPHAGUS; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ABO BLOOD-GROUP SYSTEM; ADENOCARCINOMA; BARRETT ESOPHAGUS; BLOOD GROUP ANTIGENS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; NITRIC OXIDE; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM;

EID: 80051781852     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283489dcf     Document Type: Article

References (25)

1. Bartelsman JFWM, Hameetaman W, Tytgat GN. Barrett's oesophagus. Eur J Cancer Prev 1992;1:323-325.
2. Watson A. Barrett's oesophagus - 50 years on. Br J Surg 2000;87:529-531. (Pubitemid 30261084)
3. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, et al. A multicenter, doubleblinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 2009;69:4112-4115.
4. Torrrado J, Ruiz B, Garay J, Asenjo JL, Tovar JA, Cosme A, Correa P. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus. Am J Surg Pathol 1997;21:1023-1029. (Pubitemid 27407286)
5. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-431.
6. Greer JB, Yazer MH, Raval JS, Barmada MM, Brand RE, Whitcomb DC. Significant association between ABO blood groups and pancreatic cancer. World J Gastoenterol 2010;16:5588-5591.
7. Caygill C, Charlett A, Wall C, Bardhan KD, Royston C, Gatenby PA, et al. Blood group distribution in reflux disease, columnar-lined oesophagus and oesophageal adenocarcinoma compared with the blood donating population. Gastroenterol 2009;136:A601.
8. Bardhan KD, Royston C, Nayyar AK. Reflux rising: a disease in evolution. Dig Liver Dis 2006;38:163-168.
9. Blood Transfusion Service www.blood.co.uk/pages/all-about.html [cited 3 October 2008]
10. Jankowski J, Barr H, Wang K, Delaney B. Diagnosis and management of Barrett's oesophagus. BMJ 2010;341:597-602.
11. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet 2009;373:850-861.
12. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. comparison of population-based clinical and autopsy findings. Gastroenterol 1990;99:918-922. (Pubitemid 20338445)
13. McColl KEL. When saliva meets acid: chemical warfare at the oesophagogastric junction. Gut 2005;54:1-3. (Pubitemid 40007208)
14. Bove M, Vieth M, Casselbrant A, Ny L, Lundell L, Ruth M. Acid challenge to the esophageal mucosa: effects on local nitric oxide formation and its relation to epithelial functions. Digest Dis Sci 2005;50:640-648. (Pubitemid 40558454)
15. Burton NM, Anstee DJ. Structure, function and significance Rh proteins in red cells. Curr Opin Hematol 2008;15:625-630.
16. Cerny T, Fey MF, Oppliger R, Castiglione M, Nachbur B, Gertsch M, et al. Prevalence of the Rhesus-negative phenotype in caucasian patients with small-cell lung cancer (SCLC). Int J Cancer 1992;52:504-506.
17. Bryne M, Thrana PS, Lilleng R, Dabelsteen E. Prognostic value of Rhesus blood groups in oral squamous cell carcinomas. Cancer 1991;68:2213-2216.
18. Ronco AL, Stoll M, De Stéfani E, Maisonneuve JE, Mendoza BA, Deneo-Pellegrini H. Rh factor, family history and risk of breast cancer: a case-control study in Uruguay. Cancer Detect Prev 2009;32:277-285.
19. Utada Y, Emi M, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, et al. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer. Clin Cancer Res 2000;6:3193-3198. (Pubitemid 30637747)
20. Adamian RT. Blood-type and rhesus distribution in Armenian women with endometrial carcinoma. Vopr Onkol 2005;51:575-576.
21. Hussein MR, Wood GS. Molecular aspects of melanocytic dysplastic nevi. Mol Diagn 2002;4:71-80. (Pubitemid 34555500)
22. Sulman EP, White PS, Brodeur GM. Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene 2004;23:1014-1020. (Pubitemid 38250949)
23. Ishizuka T, Tanabe C, Sakamoto H, Aoyagi K, Maekawa M, Matsukura N, et al. Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Bioph Res Commun 2002;296:152-155. (Pubitemid 35002070)
24. Ramus JR, Caygill CPJ, Gatenby PAC, Watson A. Current UK practice in the diagnosis and management of columnar-lined oesophagus; results of the UK National Barrett's Oesophagus (UKBOR) endoscopist questionnaire. Eur J Canc Prev 2008;17:422-425.
25. McDonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000;321:1252-1255.